Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36477031
2.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38296842
3.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Cancer
; 130(9): 1673-1683, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38198485
4.
What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study.
Support Care Cancer
; 32(4): 222, 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38470541
5.
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.
Int J Cancer
; 153(2): 389-398, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843260
6.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843274
7.
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
Cancer Immunol Immunother
; 72(12): 4049-4064, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37794264
8.
Hematologic malignancies following immune checkpoint inhibition for solid tumors.
Cancer Immunol Immunother
; 72(1): 249-255, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35691988
9.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36203067
10.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34605003
11.
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
Int J Cancer
; 150(2): 317-326, 2022 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34520567
12.
Frailty and checkpoint inhibitor toxicity in older patients with melanoma.
Cancer
; 128(14): 2746-2752, 2022 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35439334
13.
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
BMC Cancer
; 22(1): 705, 2022 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35761221
14.
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Ann Intern Med
; 174(5): 641-648, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33587686
15.
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(7): 1222-1230, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33495600
16.
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
Cancer Immunol Immunother
; 70(11): 3123-3135, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33774697
17.
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Int J Cancer
; 147(12): 3461-3470, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32559817
18.
The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases.
Eur Spine J
; 29(12): 3170-3178, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32948899
19.
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
Br J Cancer
; 128(5): 707-710, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36564561
20.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36319872